Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer.
暂无分享,去创建一个
Hong Wu | Yanan Yang | Wei-Wen Cai | Chad J Creighton | Mitsuo Sato | Ignacio I Wistuba | John D Minna | J. Minna | I. Wistuba | C. Creighton | W. Cai | J. Kurie | Mitsuo Sato | Hong Wu | F. DeMayo | Lijiang Ma | Jonathan M Kurie | Yanan Yang | Nishan Thilaganathan | S. Moghaddam | M. G. Raso | Kentaro Iwanaga | Maria Gabriela Raso | Lijiang Ma | Amy E Hanna | Nishan Thilaganathan | Seyed Moghaddam | Christopher M Evans | Huaiguang Li | Francesco J Demayo | C. Evans | K. Iwanaga | A. E. Hanna | Huaiguang Li | Amy E. Hanna
[1] Allan Balmain,et al. Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression. , 2004, Genes & development.
[2] Manuel Serrano,et al. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. , 2003, Cancer cell.
[3] R. DePinho,et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. , 2004, Cancer cell.
[4] M. Barbacid,et al. Tumour biology: Senescence in premalignant tumours , 2005, Nature.
[5] S. Gollin. Mechanisms leading to chromosomal instability. , 2005, Seminars in cancer biology.
[6] T. Jacks,et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice , 2001, Nature.
[7] A. Flahault,et al. Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. , 1998, The American journal of pathology.
[8] R. Price,et al. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. , 2005, Cancer research.
[9] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[10] T. Jacks,et al. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer , 2005, Nature Medicine.
[11] M. Burdick,et al. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. , 1996, The Journal of clinical investigation.
[12] A. Sica,et al. Altered macrophage differentiation and immune dysfunction in tumor development. , 2007, The Journal of clinical investigation.
[13] A. Sakurada,et al. Anticorresponding mutations of the KRAS and PTEN genes in human endometrial cancer. , 2000, Oncology reports.
[14] C. Cordon-Cardo,et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Chan,et al. Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene , 2000, Oncogene.
[16] P. Pandolfi,et al. Mouse Modeling in Oncologic Preclinical and Translational Research , 2006, Clinical Cancer Research.
[17] Li Mao,et al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] S. Lam,et al. Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] P. Pandolfi,et al. Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity , 2007, Cell.
[20] F. Haluska,et al. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. , 2000, Cancer research.
[21] G. Tonon,et al. K-ras activation generates an inflammatory response in lung tumors , 2006, Oncogene.
[22] J. Bernhagen,et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment , 2007, Nature Medicine.
[23] Pier Paolo Pandolfi,et al. The Multiple Roles of PTEN in Tumor Suppression , 2000, Cell.
[24] R. Strieter,et al. The role of CXC chemokines in pulmonary fibrosis. , 2007, The Journal of clinical investigation.
[25] B. Milleron,et al. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. , 2003, Cancer research.
[26] T. Mak,et al. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. , 2000, Cancer research.
[27] J. Murren,et al. Angiogenesis in Non-Small Cell Lung Cancer , 2002, American journal of respiratory medicine : drugs, devices, and other interventions.
[28] K. Aldape,et al. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. , 2005, Human pathology.
[29] H. Varmus,et al. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.
[30] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[31] W. Yung,et al. Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through , 2007 .
[32] W. K. Alfred Yung,et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.
[33] T. Mak,et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice , 1998, Current Biology.
[34] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] R. Brezinschek,et al. Mutation analysis of the PTEN/MMAC1 gene in lung cancer , 1998, Oncogene.
[36] R. Cardiff,et al. Classification of Proliferative Pulmonary Lesions of the Mouse , 2004, Cancer Research.
[37] C. Johannessen,et al. A negative feedback signaling network underlies oncogene-induced senescence. , 2006, Cancer cell.
[38] Charis Eng,et al. PTEN: One Gene, Many Syndromes , 2003, Human mutation.
[39] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.
[40] S. Schwartz,et al. The prevalence of PIK3CA mutations in gastric and colon cancer. , 2005, European journal of cancer.
[41] M. Iannettoni,et al. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. , 1998, The Journal of clinical investigation.
[42] Alok J. Saldanha,et al. Java Treeview - extensible visualization of microarray data , 2004, Bioinform..
[43] W. Yung,et al. Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NFκB-dependent Pathway* , 2006, Journal of Biological Chemistry.
[44] Rafael Sirera,et al. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. , 2006, Lung cancer.
[45] J. Minna,et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. , 2006, Cancer research.
[46] B. Milleron,et al. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma. , 2001, The American journal of pathology.
[47] J. Minna,et al. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. , 1991, Oncogene.
[48] M. Groszer,et al. Cre/loxP‐mediated inactivation of the murine Pten tumor suppressor gene , 2002, Genesis.
[49] H. Stein,et al. Oncogene-induced senescence as an initial barrier in lymphoma development , 2005, Nature.
[50] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[51] D. Bar-Sagi,et al. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.
[52] Tohru Takahashi,et al. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: Their heterology in form and analogy in immunohistochemical characteristics , 1996, Cancer.